P3 Health Partners Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 325.62 million compared to USD 267.1 million a year ago. Revenue was USD 329.09 million compared to USD 269.45 million a year ago. Net loss was USD 9.82 million compared to USD 154.35 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 3.71 a year ago. Diluted loss per share from continuing operations was USD 0.09 compared to USD 3.73 a year ago.
For the six months, sales was USD 624.32 million compared to USD 536.79 million a year ago. Revenue was USD 631.16 million compared to USD 543 million a year ago. Net loss was USD 19.02 million compared to USD 164.93 million a year ago. Basic loss per share from continuing operations was USD 0.25 compared to USD 3.97 a year ago. Diluted loss per share from continuing operations was USD 0.29 compared to USD 4.01 a year ago.